Vaccine formulations comprising antiidiotypic antibodies...

C - Chemistry – Metallurgy – 12 – N

Patent

Rate now

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Details

C12N 15/11 (2006.01) A01K 67/027 (2006.01) A61K 39/09 (2006.01) A61K 39/39 (2006.01) A61K 39/395 (2006.01) A61K 47/48 (2006.01) C07K 14/315 (2006.01) C07K 16/42 (2006.01) C07K 19/00 (2006.01) C12N 5/10 (2006.01) C12N 15/10 (2006.01) C12N 15/86 (2006.01) G01N 33/577 (2006.01) A61K 39/00 (2006.01)

Patent

CA 2325566

The invention relates to peptide, oligopeptide or polypeptide compounds that are capable of eliciting a protective immune response against the capsular polysaccharide of group B Streptococcus (GBS), particularly type III GBS. Such compounds are useful in the development of vaccines that are effective against diseases caused by these pathogens.

La présente invention concerne des composés peptides, oligopeptides ou polypeptides capables de susciter une réponse immunitaire de protection contre le polysaccharide capsulaire de Streptococcus du groupe B (GBS), en particulier du type III GBS. De tels composés sont utiles dans le développement de vaccins efficaces contre les maladies causées par ces pathogènes.

LandOfFree

Say what you really think

Search LandOfFree.com for Canadian inventors and patents. Rate them and share your experience with other people.

Rating

Vaccine formulations comprising antiidiotypic antibodies... does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Vaccine formulations comprising antiidiotypic antibodies..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Vaccine formulations comprising antiidiotypic antibodies... will most certainly appreciate the feedback.

Rate now

     

Profile ID: LFCA-PAI-O-1549151

  Search
All data on this website is collected from public sources. Our data reflects the most accurate information available at the time of publication.